Intercell receives The Vaccine Industry Excellence Award
Intercells Hepatitis C vaccine candidate was awarded in the category of Best New Therapeutic Vaccine at the World Vaccine Congress
28-Apr-2008 -
In the course of the World Vaccine Congress in Washington D.C., USA, Intercell was awarded The Vaccine Industry Excellence Award in the category Best New Therapeutic Vaccine for its therapeutic Hepatitis C (HCV) vaccine candidate.
Earlier this year, Intercells therapeutic vaccine candidate ...
bases
clinical trials
hepatitis C
+3